Go Back

Morningside Group

Morningside Group, a Venture Fund founded in 1986 in Shanghai, China, has a diverse investment focus across sectors like BioTech, Healthcare, Consumer Electronics, AI/ML, and more. The fund, led by Partner Ken Shi, has made 178 investments in companies such as Cognoa, Sensel, and Homee, with 31 successful exits. Morningside Group specializes in Seed to Series D stages and aims to support innovative startups in various industries, including FinTech, InsurTech, and Food and Beverage. For more information, visit their website at www.morningside.com.

About

About

About

Bio

Morningside Group invests in private equity and venture capital opportunities.

Location

Shanghai, China

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Ken Shi

Bio

Morningside Group invests in private equity and venture capital opportunities.

Location

Shanghai, China

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Ken Shi

Fund

Fund

Fund

Fund Focus

BioTech, Healthcare, Consumer Electronics, Hardware, Artificial Intelligence & Machine Learning (AI/ML), Information Technology, Food and Beverage, FinTech, Consumer, Consumer Goods, Professional Services, InsurTech, Apps

Number of investments

178

Number of exits

31

Fund Type

Venture Fund

Portfolio Companies

Cognoa, Sensel, The Nue Co., Homee, Prescryptive Health

Morningside Group

Morningside Group, a Venture Fund founded in 1986 in Shanghai, China, has a diverse investment focus across sectors like BioTech, Healthcare, Consumer Electronics, AI/ML, and more. The fund, led by Partner Ken Shi, has made 178 investments in companies such as Cognoa, Sensel, and Homee, with 31 successful exits. Morningside Group specializes in Seed to Series D stages and aims to support innovative startups in various industries, including FinTech, InsurTech, and Food and Beverage. For more information, visit their website at www.morningside.com.

About

Bio

Morningside Group invests in private equity and venture capital opportunities.

Location

Shanghai, China

Stage

Seed, Series A, Series B, Series C, Series D

Partner name

Ken Shi

Fund

Fund Focus

BioTech, Healthcare, Consumer Electronics, Hardware, Artificial Intelligence & Machine Learning (AI/ML), Information Technology, Food and Beverage, FinTech, Consumer, Consumer Goods, Professional Services, InsurTech, Apps

Number of investments

178

Number of exits

31

Fund Type

Venture Fund

Portfolio Companies

Cognoa, Sensel, The Nue Co., Homee, Prescryptive Health